Comparative evaluation of Element BioSciences AVITI and Illumina NovaSeq 6000 sequencing platforms across diverse genomic applications

Next-generation sequencing (NGS) technologies continue to evolve, requiring rigorous benchmarking to inform platform selection for diverse genomic applications. This study presents a cross-platform comparison of the Element BioSciences AVITI and Illumina NovaSeq 6000 systems across whole-genome sequencing (WGS), whole-exome sequencing (WES), and targeted panel sequencing in multiple species including Homo sapiens , Apis mellifera , and Sander lucioperca . The same biological samples and corresponding libraries were sequenced on both platforms, with AVITI libraries converted and sequenced at the manufacturer’s laboratory. AVITI consistently demonstrated higher base quality scores (Q30) across all evaluated applications, while downstream performance varied according to the sequencing application. In WGS, AVITI showed higher sequencing depth, improved ≥ 30× coverage, lower mismatch rates, and lower AT-associated coverage dropout, whereas WES showed comparable overall performance despite higher sequencing depth for Illumina. Targeted sequencing produced broadly comparable downstream results between platforms, while QuantSeq data showed highly similar gene-expression profiles between matched samples. Variant detection analyses revealed a greater number of variants for AVITI in WGS, while variant counts in WES and targeted sequencing were comparable between platforms. Single nucleotide variant concordance was high across applications, whereas indel calling showed greater platform-specific variation. The proportion of WES variants overlapping dbSNP was slightly higher for Illumina, while overlap was comparable between platforms for targeted sequencing. These results underscore the potential of AVITI for comprehensive genomic studies, with further validation warranted to elucidate clinical applicability.

Authors

Publication Details

Journal
BMC Genomics
Published
2026-11-19
DOI
https://doi.org/10.1186/s12864-026-13558-1
Primary Topic
Genomics and Phylogenetic Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparative evaluation of Element BioSciences AVITI and Illumina NovaSeq 6000 sequencing platforms across diverse genomic applications

Attila Gyenesei, Róbert Herczeg, József Kun, Bence Gálik et al.
3 links
BMC Genomics
Genomics and Phylogenetic Studies
article

Comparative evaluation of Element BioSciences AVITI and Illumina NovaSeq 6000 sequencing platforms across diverse genomic applications

Attila Gyenesei, Róbert Herczeg, József Kun, Bence Gálik, Béla Kajtár, Dániel Schmalz, Péter Urbán
article en

Abstract

Next-generation sequencing (NGS) technologies continue to evolve, requiring rigorous benchmarking to inform platform selection for diverse genomic applications. This study presents a cross-platform comparison of the Element BioSciences AVITI and Illumina NovaSeq 6000 systems across whole-genome sequencing (WGS), whole-exome sequencing (WES), and targeted panel sequencing in multiple species including Homo sapiens , Apis mellifera , and Sander lucioperca . The same biological samples and corresponding libraries were sequenced on both platforms, with AVITI libraries converted and sequenced at the manufacturer’s laboratory. AVITI consistently demonstrated higher base quality scores (Q30) across all evaluated applications, while downstream performance varied according to the sequencing application. In WGS, AVITI showed higher sequencing depth, improved ≥ 30× coverage, lower mismatch rates, and lower AT-associated coverage dropout, whereas WES showed comparable overall performance despite higher sequencing depth for Illumina. Targeted sequencing produced broadly comparable downstream results between platforms, while QuantSeq data showed highly similar gene-expression profiles between matched samples. Variant detection analyses revealed a greater number of variants for AVITI in WGS, while variant counts in WES and targeted sequencing were comparable between platforms. Single nucleotide variant concordance was high across applications, whereas indel calling showed greater platform-specific variation. The proportion of WES variants overlapping dbSNP was slightly higher for Illumina, while overlap was comparable between platforms for targeted sequencing. These results underscore the potential of AVITI for comprehensive genomic studies, with further validation warranted to elucidate clinical applicability.

BMC Genomics
Genomics and Phylogenetic Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon